Steven George Hughes
CIK 1747528 · View on SEC EDGAR ↗
First SEC filing: Jan. 8, 2025 · Latest: Jan. 8, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 16, 2019 | VIVS | S | 22,230 | $0.29 | $6,447 | 138,484 Direct | -13.83% | Disposed | -99.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (50,000) | $31.42 | Jan. 5, 2035 | 50,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (68,458) | $10.16 | Jan. 19, 2034 | 68,458 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (49,333) | $6.57 | Sept. 10, 2033 | 49,333 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (74,000) | $22.47 | Jan. 19, 2033 | 74,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (73,342) | $15.96 | Feb. 13, 2032 | 73,342 | Disposed |
| Dec. 18, 2020 | ARCT | Stock Option (right to buy) | Common Stock (50,000) | $99.29 | Dec. 18, 2030 | 50,000 | Acquired |
| Feb. 18, 2020 | ARCT | Stock Option (right to buy) | Common Stock (75,000) | $14.12 | Feb. 18, 2030 | 75,000 | Acquired |
| Aug. 14, 2018 | VIVS | Stock Option (Right to Buy) | Common Stock (974,694) | $1.12 | Aug. 14, 2028 | 974,694 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 8, 2025 | RNA | Common Stock | 61,375 | Direct |
| Jan. 8, 2025 | RNA | Stock Option (Right to Buy)→ Common Stock (64,751) | 64,751 | Direct |
| Jan. 8, 2025 | RNA | Stock Option (Right to Buy)→ Common Stock (80,167) | 80,167 | Direct |
| Jan. 8, 2025 | RNA | Stock Option (Right to Buy)→ Common Stock (92,750) | 92,750 | Direct |
| Jan. 8, 2025 | RNA | Stock Option (Right to Buy)→ Common Stock (84,625) | 84,625 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $178,779 | $37,500 | $593,936 | — | $66,885 | — | $436,392 | $1,313,492 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $460,000 | $184,000 | — | — | — | — | — | $644,000 |
| 2020 | $415,000 | $249,000 | — | — | — | — | — | $4,876,625 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.